Correlation Between Cadrenal Therapeutics, and Oncorus
Can any of the company-specific risk be diversified away by investing in both Cadrenal Therapeutics, and Oncorus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cadrenal Therapeutics, and Oncorus into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cadrenal Therapeutics, Common and Oncorus, you can compare the effects of market volatilities on Cadrenal Therapeutics, and Oncorus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cadrenal Therapeutics, with a short position of Oncorus. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cadrenal Therapeutics, and Oncorus.
Diversification Opportunities for Cadrenal Therapeutics, and Oncorus
-0.51 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Cadrenal and Oncorus is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Cadrenal Therapeutics, Common and Oncorus in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oncorus and Cadrenal Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cadrenal Therapeutics, Common are associated (or correlated) with Oncorus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oncorus has no effect on the direction of Cadrenal Therapeutics, i.e., Cadrenal Therapeutics, and Oncorus go up and down completely randomly.
Pair Corralation between Cadrenal Therapeutics, and Oncorus
If you would invest 795.00 in Cadrenal Therapeutics, Common on September 2, 2024 and sell it today you would earn a total of 724.00 from holding Cadrenal Therapeutics, Common or generate 91.07% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 1.56% |
Values | Daily Returns |
Cadrenal Therapeutics, Common vs. Oncorus
Performance |
Timeline |
Cadrenal Therapeutics, |
Oncorus |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Cadrenal Therapeutics, and Oncorus Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cadrenal Therapeutics, and Oncorus
The main advantage of trading using opposite Cadrenal Therapeutics, and Oncorus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cadrenal Therapeutics, position performs unexpectedly, Oncorus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncorus will offset losses from the drop in Oncorus' long position.The idea behind Cadrenal Therapeutics, Common and Oncorus pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Oncorus vs. Apollomics Class A | Oncorus vs. Pyxis Oncology | Oncorus vs. Zura Bio Limited | Oncorus vs. Altamira Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |